Table 3.
Table 3. Adverse Reactions Reported in the Adjuvant GIST Trial (≥ 10% of Imatinib-Treated Patients)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.